Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth.

导出 LinkOut

翻译打印收藏纠错

作者： Haroula,Kontaki ^[1] ; Marina,Koukaki ^[1] ; Maria,Vasilarou ^[1] ; Antonis,Giakountis ^[2] ; Elena,Deligianni ^[3] ; Xiaolin,Luo ^[1] ; Youngsoo,Kim ^[4] ; Iannis,Talianidis ^[4]

作者单位： Institute of Molecular Biology and Biotechnology, FORTH, 70013 Herakleion, Crete, Greece. ^[1] Department of Biology, University of Crete, 70013 Herakleion, Crete, Greece. ^[2] Department of Biochemistry and Biotechnology, University of Thessaly, Larissa 41500, Greece. ^[3] Ionis Pharmaceuticals, Carlsbad, CA, USA. ^[4]

关键词 Cancer Epigenetics

DOI 10.1016/j.isci.2021.102473

PMID 34113819

发布时间 2021-06-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

iScience

2021年24卷5期

102473页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth.

iScience

相似文献

iScience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth.

iScience

相似文献

iScience

相关期刊

检索历史清除